Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Anticancer Drugs Market, by Region, 2018-2027 (USD Billion)
1.2.2. Anticancer Drugs Market, by Drug Type, 2018-2027 (USD Billion)
1.2.3. Anticancer Drugs Market, by Therapy Type, 2018-2027 (USD Billion)
1.2.4. Anticancer Drugs Market, by Cancer Type, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Anticancer Drugs Market Definition & Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Anticancer Drugs Market Dynamics
3.1. Anticancer Drugs Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Anticancer Drugs Market: Industry Analysis
4.1. Porters 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porters 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Anticancer Drugs Market, by Drug Type
5.1. Market Snapshot
5.2. Global Anticancer Drugs Market by Drug Type, Performance - Potential Analysis
5.3. Global Anticancer Drugs Market Estimates & Forecasts by Drug Type, 2017-2027 (USD Billion)
5.4. Anticancer Drugs Market, Sub Segment Analysis
5.4.1. Cytotoxic Drugs
5.4.2. Targeted Drugs
5.4.3. Hormonal Drugs
Chapter 6. Global Anticancer Drugs Market, by Therapy Type
6.1. Market Snapshot
6.2. Global Anticancer Drugs Market by Therapy Type, Performance - Potential Analysis
6.3. Global Anticancer Drugs Market Estimates & Forecasts by Therapy Type, 2017-2027 (USD Billion)
6.4. Anticancer Drugs Market, Sub Segment Analysis
6.4.1. Chemotherapy
6.4.2. Targeted Therapy
6.4.3. Immunotherapy
6.4.4. Others
Chapter 7. Global Anticancer Drugs Market, by Cancer Type
7.1. Market Snapshot
7.2. Global Anticancer Drugs Market by Cancer Type, Performance - Potential Analysis
7.3. Global Anticancer Drugs Market Estimates & Forecasts by Cancer Type, 2017-2027 (USD Billion)
7.3.1. Lung Cancer
7.3.2. Breast Cancer
7.3.3. Leukaemia
7.3.4. Colorectal Cancer
7.3.5. Others
Chapter 8. Global Anticancer Drugs Market, Regional Analysis
8.1. Anticancer Drugs Market, Regional Market Snapshot
8.2. North America Anticancer Drugs Market
8.2.1. U.S. Anticancer Drugs Market
8.2.1.1. Drug Type breakdown estimates & forecasts, 2017-2027
8.2.1.2. Therapy Type breakdown estimates & forecasts, 2017-2027
8.2.1.3. Cancer Type breakdown estimates & forecasts, 2017-2027
8.2.2. Canada Anticancer Drugs Market
8.3. Europe Anticancer Drugs Market Snapshot
8.3.1. U.K. Anticancer Drugs Market
8.3.2. Germany Anticancer Drugs Market
8.3.3. France Anticancer Drugs Market
8.3.4. Spain Anticancer Drugs Market
8.3.5. Italy Anticancer Drugs Market
8.3.6. Rest of Europe Anticancer Drugs Market
8.4. Asia-Pacific Anticancer Drugs Market Snapshot
8.4.1. China Anticancer Drugs Market
8.4.2. India Anticancer Drugs Market
8.4.3. Japan Anticancer Drugs Market
8.4.4. Australia Anticancer Drugs Market
8.4.5. South Korea Anticancer Drugs Market
8.4.6. Rest of Asia Pacific Anticancer Drugs Market
8.5. Latin America Anticancer Drugs Market Snapshot
8.5.1. Brazil Anticancer Drugs Market
8.5.2. Mexico Anticancer Drugs Market
8.6. Rest of The World Anticancer Drugs Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. F. Hoffmann-La Roche Ltd
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Industry Summary
9.2.1.5. Recent Developments
9.2.2. Eli Lilly and Company
9.2.3. Novartis AG
9.2.4. Pfizer Inc
9.2.5. Bayer AG
9.2.6. AstraZeneca
9.2.7. Takeda Pharmaceutical Company Limited
9.2.8. Merck & Co., Inc.
9.2.9. CELGENE CORPORATION
9.2.10. Amgen Inc
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption